Sunday, March 08

Top Stories

February 15, 2026

Ahead of Market: 10 key factors to steer markets on Monday

Indian benchmark indices closed sharply lower on Friday, dragged down by broad-based selling across sectors. Consumer, IT, and energy stocks were among the biggest laggards.The Nifty settled at 25,471.10, down 336 points or 1.30%, while the BSE Sensex tumbled 1,048.16 points, or 1.25%, to close at 82,626.76.The volatility gauge, India VIX, ended at 11.73, down 1.53% from the previous close.Analysts’ TakeNilesh Jain, Vice President – Head of Technical & Derivative Research at Centrum Finverse, said the Nifty opened with a gap-down and slipped below its key 21-, 50-, and 100-day moving averages, placed at 25,480, 25,770, and 25,690, respectively.The index is attempting to fill last week’s downside gap, and the crucial support at the 200-DMA near 25,300 is likely to be tested in the

February 15, 2026

Can India keep up with the US in AI race?

Chapel Hill, North Carolina: Last week, the US Department of Energy announced 26 'science and technology challenges of national importance' to advance the Genesis Mission, an initiative launched last November by the US to accelerate scientific research through AI. More than this being about using AI to speed up research, it's about letting machines build how science is imagined, tested and advanced, reducing years of discovery into weeks. When the pace of science changes, the balance of global power changes with it. What Washington announced last week was not another AI policy. It was a declaration that speed of scientific discovery has itself become a strategic asset. New Delhi should heed this. As it hosts AI Impact Summit 2026, it needs to confront a harder truth: when it comes to infra

February 15, 2026

GST revamp to help cut cancer care costs

Recent changes to the Goods and Services Tax (GST) framework -- simplified tax structure, removal of tax on drugs and medical equipment and increased taxation on tobacco products -- mark an important policy shift towards making cancer care more affordable and accessible, AIIMS researchers have said.In a commentary published in Frontier, Oncologist Dr Abhishek Shankar and Scientist Dr Vaibhav Sahni from the Department of Radiation Oncology, Dr BR Ambedkar Institute Rotary Cancer Hospital, AIIMS, Delhi, noted that the reforms acknowledge the financial toxicity faced by cancer patients and attempt to address long-standing gaps in treatment affordability.The researchers mentioned that the GST council, in its 56th meeting, recommended the total exemption of 33 lifesaving drugs, including those

23